Renal cell cancer (RCC) is a highly vascularized and immunogenic tumor type. The inhibition
of vessel formation by anti-angiogenic therapies, as well as the stimulation of the immune …

… Tumor Resection and Ablative Therapies RN remains the conventional therapy for large
renal masses and nonlocalized tumors… therapies, are emerging as mainstream therapies for …

… In our material [282], 97 renal tumor autopsies were seen in 3512 postmortem exams.
Half of the detected tumors were benign; among the malignant tumors, the papillary type was …

… biology that have provided insight into the alterations underlying these renal cortical tumor
… understanding of these renal cortical tumors, the crucial biological pathways that become …

… Since the biology of renal cell cancer (RCC) is tightly controlled by mTOR, targeted … in
RCC biology as well as clinical efficacy of mTOR inhibitors in the treatment of renal cell cancer. …

… This review provides a comprehensive overview of the current biological knowledge of
childhood renal tumours alongside the progress achieved through international collaboration. …

… subtypes such as renal medullary carcinoma and … tumors. Herein, we provide guidance on
how to choose appropriate treatment of vhRCCs based on our evolving clinical and biological …

… insufficient to generate tumors [20], HIF continues to play an important role in the tumorigenicity
of established RCCs [21]. Disruption of translocation in renal carcinoma, chromosome 8 …

… renal cancer field to leverage new knowledge into developing diagnostic and therapeutic …
to be diagnosed with cancer of the kidney and renal pelvis in 2013, and 13,680 are estimated …

… Accordingly, a popular strategy for molecular-targeted therapy for RCC targets the …
highlights the biological features of RCC that are rel- evant to molecular-targeted therapy. (…